InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,426.40
(
0.12%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.78
(
-0.01%
)
Bitcoin
65,386.73
(
0.38%
)
Post# of 252254
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 834
Posts 119875
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 140906

Friday, 04/27/2012 8:55:51 AM

Friday, April 27, 2012 8:55:51 AM

Post# of 252254
From the same PKI newswire:

PerkinElmer tweaked its full-year forecast range and now expects to earn $2.00 to $2.05 per share excluding items. (It had previously forecast $1.98 to $2.04 per share.)

…The Human Health division, which includes neonatal testing and other diagnostic equipment, saw sales jump 26 percent to $254.0 million [this includes the effect of the CALP acquisition].

PKI also reported >20% organic growth (i.e. excluding the CALP acquisition) in the BRIC countries (http://seekingalpha.com/article/534591-perkinelmer-s-ceo-discusses-q1-2012-results-earnings-call-transcript ).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up